- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07707102
Advancing Skills Through Consultation, Education, and Novel Technologies (ASCENT)
Increasing the Reach of Evidence-Based PTSD Treatment: Development and Clinical Trial of Artificial Intelligence (AI)-Facilitated, Web-Based Written Exposure Therapy Training
This research study tests strategies to train behavioral health providers in Written Exposure Therapy (WET), an evidence-based treatment for posttraumatic stress disorder (PTSD). There are a number of evidence-based treatments for posttraumatic stress disorder (PTSD). However, most behavioral health providers have not received training in these PTSD treatments and do not offer them regularly to their patients.
The researchers hope to learn about the optimal way to train behavioral providers in this type of treatment. This study is designed to determine the comparative effectiveness of different training strategies on key outcomes such as how much competency providers develop in the therapy and to how many patients they deliver the therapy. This study will help the researchers understand if we can help more providers learn to competently delivery Written Exposure Therapy by using strategies that are more convenient and cost less money, including web-based and AI-facilitated training supports. This study will also help us learn which training strategies work best for which providers so that in the future we can make personalized training recommendations.
Visão geral do estudo
Status
Descrição detalhada
This study will enroll behavioral health providers (i.e., professional therapists) and test a training program for Written Exposure Therapy that includes
- an enhanced, web-based foundational training (web-based training plus integrated TherapyTrainer components) and
- an AI training support tool for competency development (TherapyTrainer).
This randomized clinical trial will compare web/AI training, among providers who serve Veterans and Service Members, to standard Written Exposure Therapy training (i.e., human-delivered live workshop and consultation calls) on provider, patient, and cost-effectiveness outcomes. There is no cross-over of conditions. Providers in both conditions will be eligible to earn continuing education credits and approval as Written Exposure Therapy Providers who have completed competency based training and two training cases.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Stefanie Losavio, PhD
- Número de telefone: (210) 562-6714
- E-mail: ASCENT@uthscsa.edu
Locais de estudo
-
-
Texas
-
San Antonio, Texas, Estados Unidos, 78229
- Recrutamento
- University of Texas Health Science Center at San Antonio
-
Contato:
- Stefanie LoSavio, PhD
- Número de telefone: 210-562-6714
- E-mail: losavio@uthscsa.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- mental health provider;
- serves veterans and/or service members with PTSD (by self-report);
- willing to participate in either live or web-based training.
Exclusion Criteria:
1. has already completed formal training in Written Exposure Therapy
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Workshop + Consultation Calls
10-hour, live workshop over 2 days with a live trainer via video conferencing.
There will also be twelve 1 hour calls with a live therapy consultant .
|
Approximately 10 hours (excluding breaks) over 2 days with a live trainer via video conferencing (e.g., Zoom)
Twelve 1-hour calls with a live therapy consultant via videoconferencing (e.g., Zoom)
|
|
Comparador Ativo: Workshop + TherapyTrainer
10-hour, live workshop over 2 days with a live trainer via video conferencing.There will also be approximately 12 hours of engagement with the AI training support tool (TherapyTrainer)
|
Approximately 10 hours (excluding breaks) over 2 days with a live trainer via video conferencing (e.g., Zoom)
No live meetings, but approximately 12 hours of engaging with the AI training support tool (TherapyTrainer)
Outros nomes:
|
|
Comparador Ativo: Web-Based Training + Consultation Calls
AI enhanced Web-based training with no live meetings, but approximately 8-10 hours of asynchronous, self-paced training.
There will also be twelve 1 hour calls with a live therapy consultant .
|
Twelve 1-hour calls with a live therapy consultant via videoconferencing (e.g., Zoom)
No live meetings, but approximately 8-10 hours of asynchronous training at the learner's pace over about 1 month.
|
|
Comparador Ativo: Web-based Training + TherapyTrainer
AI enhanced Web-based training with no live meetings, but approximately 8-10 hours of asynchronous, self-paced training.
There will also be approximately 12 hours of engagement with the AI training support tool (TherapyTrainer)
|
No live meetings, but approximately 12 hours of engaging with the AI training support tool (TherapyTrainer)
Outros nomes:
No live meetings, but approximately 8-10 hours of asynchronous training at the learner's pace over about 1 month.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Provider WET Competency
Prazo: Baseline to 7 months
|
A 20-item multiple choice treatment knowledge assessment.
Higher scores indicate greater knowledge of WET.
|
Baseline to 7 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Completion of Practice Cases
Prazo: 4 months
|
Number of participants that complete practice cases
|
4 months
|
|
Time to complete Practice Cases
Prazo: 4 months
|
Number of days to complete two training cases (real or simulated)
|
4 months
|
Colaboradores e Investigadores
Colaboradores
Investigadores
- Investigador principal: Stefanie LoSavio, PhD, The University of Texas Health Science Center at San Antonio
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- STUDY00002482
- HT9425-25-1-0585 (Número de outro subsídio/financiamento: Department of Defense)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .